公佈財報後,蔚來汽車盤前跌2.5%
蔚來汽車(NIO.N):於2022年第一季度的車輛毛利率爲18.1%,而2021年第一季度爲21.2%、2021年第四季度爲20.9%。車輛毛利率較2021年第一季度有所下降,主要由於我們的產品組合比例變動導致平均售價下降。
蔚來汽車(NIO.N):預計第二季度車輛交付量爲23,000輛至25,000輛,較2021年第二季度增長約5.0%至14.2%;收入總額爲人民幣93.40億元至人民幣100.88億元,較2021年第二季度增長約10.6%至19.4%。
蔚來汽車(NIO.N):於2022年第一季度其他銷售收入爲人民幣6.666億元,較2021年第一季度增長15.6%、較2021年第四季度下降2.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.